Clinical Supply Management Articles

1. From Passive To Predictive: The New Era Of Clinical Cold Chain Management 4/16/2026

   Temperature-sensitive drugs demand a cold chain that predicts disruptions, manages risks, and coordinates globally to keep trials on time and patients safe.

2. 6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening 4/14/2026

   Expert-recommended "once‑in‑a‑lifetime" testing for Lp(a) introduces new clinical supply risks as screening drives volatility, longer treatment, and inventory strain.

3. Where Trial Budgets And Supply Plans Go Off Track — Earlier Than You Think 4/14/2026

   Misaligned assumptions in contracts and budgets quietly derail supply plans, driving rework, delays, and execution risk long before issues surface.

4. From Policy To Practice: Embedding Export Compliance In Clinical Supply 4/13/2026

   Export compliance in clinical supply cannot be an afterthought. Embedding it into workflows, training, and decision making reduces risk while improving speed and coordination.

5. What CAPAs Don't Catch: 3 Hidden ATMP Cold Chain Vulnerabilities By Design 4/10/2026

   Cold chain failures in ATMPs often stem from hidden design flaws, not execution errors. Learn how overlooked material, process, and preservation choices drive risk.

6. AI And Digital Tools Advance Clinical Trial Supply Chains 4/9/2026

   AI is reshaping trial supply with smarter forecasting, risk detection, and real-time control, cutting waste, preventing delays, and turning data into decisive action.

7. The Hidden Bottleneck: Clinical Supply Strategy In Study Start-Up 4/7/2026

   Delays in clinical trials often hide in late supply planning. Early integration of supply strategy ensures product availability, reduces risk, and keeps studies on schedule.

8. Why More Tools Won't Fix Clinical Supply 4/6/2026

   Clinical supply fails when tools outpace the operating model. Clear workflows, governance, trusted records, and adoption strategies create scalable, reliable supply.

9. The Hidden Supply Chain Risks That Can Derail Small Biotech Trials 4/3/2026

   Small biotech trials face hidden supply risks that waste up to 75% of materials, delay timelines, and drain funding faster. Learn what causes them and how to prevent them.

10. The RTSM–EDC Integration Trap: Why Broken Workflows Still Undermine Trial Execution 3/31/2026

    Broken RTSM–EDC integrations keep clinical trials stalled with blocked randomizations, kit errors, and endless reconciliations. Here’s how to fix workflows before tech fails.